Thermo Fisher Scientific's $13.6 Billion Acquisition of Life Technologies Boosts Flagging M&A Numbers May 01, 2013 | Press Release
Burrill Securities Launches Institutional Breakthrough Series April 29, 2013 | Press Release
Big Biotech Outpaces Big Pharma, Burrill & Company says April 16, 2013 | Press ReleaseSee all News
Before joining Burrill, Garrett was with Genentech’s Market Planning Group where he focused on the commercialization and launch of Lucentis for the treatment of age-related macular degeneration. Garrett previously worked with the Health Care Investment Banking group at Cowen and in Business Development at EntreMed.
Garrett is a co-instructor at UCSF’s Center for BioEntrepreneurship’s “Idea to IPO” course and has advised in the formation of numerous biotech start-ups. Garrett completed his Transitional Residency at the